Cargando…
Common variable immunodeficiency unmasked by treatment of immune thrombocytopenic purpura with Rituximab
BACKGROUND: Hypogammaglobulinemia may be part of several different immunological or malignant conditions, and its origin is not always obvious. Furthermore, although autoimmune cytopenias are known to be associated with common variable immunodeficiency (CVID) and even may precede signs of immunodefi...
Autores principales: | Mogensen, Trine H, Bernth-Jensen, Jens Magnus, Petersen, Charlotte C, Petersen, Mikkel S, Nyvold, Charlotte, Gadegaard, Karsten H, Hokland, Marianne, Hokland, Peter, Larsen, Carsten S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776283/ https://www.ncbi.nlm.nih.gov/pubmed/24499503 http://dx.doi.org/10.1186/2052-1839-13-4 |
Ejemplares similares
-
Identification of Novel Genetic Variants in CVID Patients With Autoimmunity, Autoinflammation, or Malignancy
por: Christiansen, Mette, et al.
Publicado: (2020) -
Thrombotic thrombocytopenic purpura treated with rituximab in systemic lupus erythematosus
por: Karimifar, Mansoor
Publicado: (2012) -
Rituximab as first-line treatment for acquired thrombotic thrombocytopenic purpura
por: Chen, Haifei, et al.
Publicado: (2017) -
Thrombocytopenic purpura associated with common variable immunodeficiency and bronchiectasis
por: Souza, Thais Martins
Publicado: (2015) -
Novel scripts for improved annotation and selection of variants from whole exome sequencing in cancer research
por: Hansen, Marcus Celik, et al.
Publicado: (2015)